If PLS3 does alter severity of SMA, defining the role of both PLS3 rs871773 and the hypomethylation of sites 95–99 is important as it gives a mechanism of PLS3 activation and may even result in a DNA marker that could be followed in patient material. This evidence concerns the gene PLS3 and proximal spinal muscular atrophy.